| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |